Allergy to short-acting β2-agonists in a COPD patient: Is an immunological mechanism involved?

Allergol Immunopathol (Madr). 2015 May-Jun;43(3):329-30. doi: 10.1016/j.aller.2014.04.003. Epub 2014 Aug 3.

Authors

L Manso¹, T Valbuena², M A Padial², M Reche², M P Zafra³, V Del Pozo³, C Y Pascual²

Affiliations

¹ Unidad de Alergología, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain. Electronic address: [email protected].
² Unidad de Alergología, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
³ Servicio de Inmunología, Fundación Jiménez Díaz, Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Spain.

PMID: 25097024
DOI: 10.1016/j.aller.2014.04.003

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adrenergic beta-2 Receptor Antagonists / therapeutic use*
Albuterol / administration & dosage*
Albuterol / immunology
Allergens / immunology
Anaphylaxis / diagnosis*
Anaphylaxis / etiology
Anaphylaxis / immunology
Basophil Degranulation Test
Cross Reactions
Drug Hypersensitivity / complications
Drug Hypersensitivity / diagnosis*
Drug Hypersensitivity / immunology
Humans
Immunoglobulin E / immunology
Male
Middle Aged
Muscle, Smooth / drug effects
Pulmonary Disease, Chronic Obstructive / complications
Pulmonary Disease, Chronic Obstructive / diagnosis*
Pulmonary Disease, Chronic Obstructive / immunology
Terbutaline / administration & dosage
Terbutaline / immunology

Substances

Adrenergic beta-2 Receptor Antagonists
Allergens
Immunoglobulin E
Terbutaline
Albuterol